Ariad Pharmaceuticals Inc

The U.S. Court of Appeals for the Federal Circuit, on June 1, 2009, affirmed the U.S. District Court for the District of Delaware’s ruling on claim construction and non-infringement in…

Oral argument on Ariad Pharmaceuticals Inc.’s appeal from the U.S. District Court for the District of Delaware’s patent infringement ruling in favor of Amgen Inc. remains to be scheduled.

On April…